Search research articles
Contact Us
Filters
Showing results (331-340 of 352) with videos related to
Page
of 36
Sort By:
Intensive Care Medicine
|
May 9, 2020
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper<sub>.</sub>
Mohd H Abdul-Aziz, Jan-Willem C Alffenaar, Matteo Bassetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability
Irena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
The Pediatric Infectious Disease Journal
|
January 13, 2023
Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series
Cornelius Rau, Lorenz Auer-Hackenberg, Hedwig E Deubzer, et al.
Infectious Agents and Cancer
|
February 14, 2023
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
Maximilian J Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 4, 2026
Prostatic tissue distribution of gepotidacin in patients undergoing prostatectomy: an ex-vivo microdialysis and pharmacokinetic modelling study
Valentin Al Jalali, Vincent Aranzana-Climent, Anselm Jorda, et al.
Clinical Pharmacokinetics
|
July 30, 2020
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents
Markus Zeitlinger, Birgit C P Koch, Roger Bruggemann, et al.
Medical Microbiology and Immunology
|
March 6, 2025
Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial
Anselm Jorda, Lena Pracher, Sabine Eberl, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
October 25, 2023
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study
Jason A Roberts, Fekade Sime, Jeffrey Lipman, et al.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Intensive Care Medicine
|
February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study
Jason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 352) with videos related to
Sort By:
Page
of 36
Intensive Care Medicine
|
May 9, 2020
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper<sub>.</sub>
Mohd H Abdul-Aziz, Jan-Willem C Alffenaar, Matteo Bassetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability
Irena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
The Pediatric Infectious Disease Journal
|
January 13, 2023
Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series
Cornelius Rau, Lorenz Auer-Hackenberg, Hedwig E Deubzer, et al.
Infectious Agents and Cancer
|
February 14, 2023
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
Maximilian J Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 4, 2026
Prostatic tissue distribution of gepotidacin in patients undergoing prostatectomy: an ex-vivo microdialysis and pharmacokinetic modelling study
Valentin Al Jalali, Vincent Aranzana-Climent, Anselm Jorda, et al.
Clinical Pharmacokinetics
|
July 30, 2020
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents
Markus Zeitlinger, Birgit C P Koch, Roger Bruggemann, et al.
Medical Microbiology and Immunology
|
March 6, 2025
Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial
Anselm Jorda, Lena Pracher, Sabine Eberl, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
October 25, 2023
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study
Jason A Roberts, Fekade Sime, Jeffrey Lipman, et al.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Intensive Care Medicine
|
February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study
Jason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
Page
of 36